# Age-Related Vision Treatments Viatris' RYZUMVI Eye Drops Receive FDA Approval for Presbyopia By Mursal Rahman | Written with AI assistance | Published 2026-10-19 | Lifestyle Source: Trend Hunter, https://www.trendhunter.com/trends/age-related-vision-treatments References: [prnewswire](https://www.prnewswire.com/news-releases/viatris-receives-us-fda-approval-for-ryzumvi-for-the-treatment-of-presbyopia-302911593.html)  Viatris is expanding age-related vision treatments with the FDA approval of [RYZUMVI eye drops](https://www.trendhunter.com/trends/eye-drops1) for adults experiencing presbyopia. Previously authorized to reverse medication-induced pupil dilation, the [prescription solution](https://www.trendhunter.com/trends/prescription-dermatology) now addresses a second eye condition. This expanded application offers another treatment option for individuals experiencing difficulty focusing on nearby objects as they age. RYZUMVI contains phentolamine ophthalmic solution 0.75% and targets presbyopia, a condition commonly emerging during a person's early to mid-40s. The medication's existing approval also covers reversing drug-induced pupil dilation in adults and children aged three and older. Its additional indication broadens the product's clinical applications. The approval creates opportunities for Viatris to reach a wider patient population within the [ophthalmic pharmaceutical market](https://www.trendhunter.com/trends/ophthalmic-technology). The company is considering a U.S. commercialization partner, potentially supporting distribution and expanding its presence in age-related vision care. Image Credit: Viatris ## Trend Insights (Trend Hunter) - Score: 6.1/10 - Popularity: 35% | Activity: 49% | Freshness: 98% - Audience gender: 50% men, 50% women - Primary generations: Millennial, Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Lifestyle](https://www.trendhunter.com/lifestyle) > [Health](https://www.trendhunter.com/health) ## Key Themes ### Key Themes Behind This Trend - **Multi-indication Eye Drops:** Expanded ophthalmic approvals reveal room for repurposed prescription eye drops that address multiple vision needs across patient age groups. - **Aging Vision Therapies:** Rising presbyopia prevalence creates a growing market for noninvasive treatments that support near-vision correction without relying solely on glasses or procedures. - **Ophthalmic Commercial Partnerships:** Pharmaceutical collaborations in eye care can accelerate distribution, patient access, and market expansion for specialized vision treatments. ### Where This Applies - **Ophthalmic Pharmaceuticals:** Age-related eye conditions are fueling demand for targeted prescription formulations with broader clinical use cases. - **Vision Care:** Consumer reliance on reading glasses and corrective devices leaves space for therapeutic alternatives that fit into everyday eye health routines. - **Healthcare Distribution:** Partner-led commercialization models are becoming important for scaling specialty medications across clinics, pharmacies, and patient networks. ## Related on Trend Hunter - [Adaptive Autofocus Glasses](https://www.trendhunter.com/trends/ixi-eyewear.md) - [VR Pediatric Treatments](https://www.trendhunter.com/trends/luminopia.md) - [Age-Related Ocular Degeneration Drops](https://www.trendhunter.com/trends/tenpoint-yuvezzi.md) - [Myopia-Focused Contact Lenses](https://www.trendhunter.com/trends/myopia-control.md) - [Migraine-Filtering Eyewear](https://www.trendhunter.com/trends/avulux-lenses.md) - [Targeted Prescription-Based Kits](https://www.trendhunter.com/trends/primera-professional-pharmacy.md) - [Preservative-Free Eye Drops](https://www.trendhunter.com/trends/similasan-eye-drops.md) - [Generic Pulmonary Hypertension Drugs](https://www.trendhunter.com/trends/generic-pulmonary-hypertension-tablets.md) - [Multi-Action Dry Eye Drops](https://www.trendhunter.com/trends/eyes-for-hours.md)